Cannara Biotech Inc. (LOVE.V)
CAD 1.42
(-1.39%)
CAD 1.42
(-1.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 61.77 Million CAD | 4.92% |
| 2022 | 58.88 Million CAD | 110.99% |
| 2021 | 27.9 Million CAD | 69.28% |
| 2020 | 16.48 Million CAD | -9.29% |
| 2019 | 18.17 Million CAD | 28.73% |
| 2018 | 14.11 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 62.96 Million CAD | 1.92% |
| 2024 Q3 | 67 Million CAD | 0.78% |
| 2024 Q2 | 66.48 Million CAD | 5.59% |
| 2023 Q1 | 58.14 Million CAD | -1.25% |
| 2023 Q4 | 61.77 Million CAD | 2.28% |
| 2023 FY | 61.77 Million CAD | 4.92% |
| 2023 Q3 | 60.39 Million CAD | 5.27% |
| 2023 Q2 | 57.37 Million CAD | -1.32% |
| 2022 Q2 | 39.14 Million CAD | 1.37% |
| 2022 Q1 | 38.61 Million CAD | 38.38% |
| 2022 FY | 58.88 Million CAD | 110.99% |
| 2022 Q4 | 58.88 Million CAD | 38.05% |
| 2022 Q3 | 42.65 Million CAD | 8.95% |
| 2021 Q4 | 27.9 Million CAD | 30.22% |
| 2021 Q2 | 19.96 Million CAD | 20.77% |
| 2021 FY | 27.9 Million CAD | 69.28% |
| 2021 Q1 | 16.53 Million CAD | 0.3% |
| 2021 Q3 | 21.43 Million CAD | 7.32% |
| 2020 FY | 16.48 Million CAD | -9.29% |
| 2020 Q4 | 16.48 Million CAD | 1.34% |
| 2020 Q3 | 16.26 Million CAD | 5.73% |
| 2020 Q1 | 14.63 Million CAD | -19.45% |
| 2020 Q2 | 15.38 Million CAD | 5.1% |
| 2019 Q4 | 18.17 Million CAD | 4.67% |
| 2019 FY | 18.17 Million CAD | 28.73% |
| 2019 Q3 | 17.36 Million CAD | -23.53% |
| 2019 Q1 | 13.72 Thousand CAD | 0.0% |
| 2019 Q2 | 22.7 Million CAD | 165317.08% |
| 2018 FY | 14.11 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -1048.28% |
| CanadaBis Capital Inc. | 15.61 Million CAD | -295.535% |
| Decibel Cannabis Company Inc. | 96.79 Million CAD | 36.174% |
| Delivra Health Brands Inc. | 4.85 Million CAD | -1171.68% |
| Entourage Health Corp. | 178.68 Million CAD | 65.427% |
| Lifeist Wellness Inc. | 9.94 Million CAD | -521.469% |
| Medicure Inc. | 8.16 Million CAD | -656.808% |
| PharmaCielo Ltd. | 23.96 Million CAD | -157.742% |
| Rubicon Organics Inc. | 16.99 Million CAD | -263.471% |
| BioSyent Inc. | 6.76 Million CAD | -812.639% |
| Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -8387.452% |